Isoxicam

CAS No. 34552-84-6

Isoxicam( Isoxicam | W 8495 | W-8495 | W8495 | BRN 0577221 )

Catalog No. M14182 CAS No. 34552-84-6

Isoxicam is a novel and long-acting, non-steroidal anti-inflammatory drugs, used to treat arthritis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 37 In Stock
100MG 60 In Stock
200MG 100 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isoxicam
  • Note
    Research use only, not for human use.
  • Brief Description
    Isoxicam is a novel and long-acting, non-steroidal anti-inflammatory drugs, used to treat arthritis.
  • Description
    Isoxicam is a novel and long-acting, non-steroidal anti-inflammatory drugs, used to treat arthritis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Isoxicam | W 8495 | W-8495 | W8495 | BRN 0577221
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34552-84-6
  • Formula Weight
    335.34
  • Molecular Formula
    C14H13N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NOC(C)=C3
  • Chemical Name
    2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-3-isoxazolyl)-, 1,1-dioxide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Burch FX. Am J Med. 1985 Oct 18;79(4B):28-32.
molnova catalog
related products
  • Ebselen

    Ebselen is a mimic of glutathione peroxidase and can also react with peroxynitrite.

  • DuP-697

    DuP-697 is an irreversible, specific COX-2 inhibitor with IC50 values ??of 10 nM and 800 nM for human COX-2 and COX-1. DuP-697 also exhibits anti-angiogenic, anti-inflammatory, antipyretic and apoptotic effects.

  • (S)-( )-Ibuprofen

    An enantiomer of Ibuprofen that more potently inhibits COX activity, thromboxane formation, and platelet aggregation than the (R)-form.